Search research articles
Contact Us
Filters
Showing results (11-20 of 115) with videos related to
Page
of 12
Sort By:
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
|
April 16, 2016
Reply
Linda Zheng, Mark Gillies, Frank J Martin
Retina (Philadelphia, Pa.)
|
May 20, 2014
Reasons for discontinuation of intravitreal vascular endothelial growth factor inhibitors in neovascular age-related macular degeneration
Anagha Vaze, Samantha Fraser-Bell, Mark Gillies
Expert Opinion on Pharmacotherapy
|
December 17, 2009
Pharmacotherapeutic efficacy of preservative-free intravitreal triamcinolone acetonide
Chih-Hung Kuo, Peter McCluskey, Mark Gillies
Clinical & Experimental Optometry
|
March 21, 2012
Clinical development of new treatments for diabetic macular oedema
Wedad Salem, Samantha Fraser-Bell, Mark Gillies
Acta Ophthalmologica
|
April 23, 2014
Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration
Anagha Vaze, Samantha Fraser-Bell, Mark Gillies
Lancet (London, England)
|
March 4, 2008
Fenofibrate and diabetic retinopathy
Gerald Liew, Mark Gillies, Jie Jin Wang
Therapeutic Advances in Chronic Disease
|
September 4, 2015
Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema
Hemal Mehta, Mark Gillies, Samantha Fraser-Bell
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
|
October 22, 2015
Central retinal vein occlusion in an otherwise healthy child treated successfully with a single injection of bevacizumab
Linda Zheng, Mark Gillies, Frank J Martin
Clinical & Experimental Ophthalmology
|
March 29, 2012
Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema
Saumil Sheth, Ryan Rush, Sundaram Natarajan, et al.
Clinical & Experimental Ophthalmology
|
November 14, 2025
Macular Atrophy in the Better-Seeing Eye of Australian Patients Treated for Neovascular Age-Related Macular Degeneration
Yohei Hashimoto, Ian Reddie, Zanne Louw, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 115) with videos related to
Sort By:
Page
of 12
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
|
April 16, 2016
Reply
Linda Zheng, Mark Gillies, Frank J Martin
Retina (Philadelphia, Pa.)
|
May 20, 2014
Reasons for discontinuation of intravitreal vascular endothelial growth factor inhibitors in neovascular age-related macular degeneration
Anagha Vaze, Samantha Fraser-Bell, Mark Gillies
Expert Opinion on Pharmacotherapy
|
December 17, 2009
Pharmacotherapeutic efficacy of preservative-free intravitreal triamcinolone acetonide
Chih-Hung Kuo, Peter McCluskey, Mark Gillies
Clinical & Experimental Optometry
|
March 21, 2012
Clinical development of new treatments for diabetic macular oedema
Wedad Salem, Samantha Fraser-Bell, Mark Gillies
Acta Ophthalmologica
|
April 23, 2014
Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration
Anagha Vaze, Samantha Fraser-Bell, Mark Gillies
Lancet (London, England)
|
March 4, 2008
Fenofibrate and diabetic retinopathy
Gerald Liew, Mark Gillies, Jie Jin Wang
Therapeutic Advances in Chronic Disease
|
September 4, 2015
Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema
Hemal Mehta, Mark Gillies, Samantha Fraser-Bell
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
|
October 22, 2015
Central retinal vein occlusion in an otherwise healthy child treated successfully with a single injection of bevacizumab
Linda Zheng, Mark Gillies, Frank J Martin
Clinical & Experimental Ophthalmology
|
March 29, 2012
Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema
Saumil Sheth, Ryan Rush, Sundaram Natarajan, et al.
Clinical & Experimental Ophthalmology
|
November 14, 2025
Macular Atrophy in the Better-Seeing Eye of Australian Patients Treated for Neovascular Age-Related Macular Degeneration
Yohei Hashimoto, Ian Reddie, Zanne Louw, et al.
Page
of 12